FICB group n = 45 | control group n = 44 | test value | P-value | |
---|---|---|---|---|
Age (yr), Median [IQR] | 74 [70 to 78] | 72 [67 to 77] | 986.5 | 0.977 |
Male sex, N (%) | 16 (35.6%) | 18 (40.9%) | 0.270 | 0.603 |
BMI (kg/m2), Mean ± SD | 22.64 ± 2.60 | 22.12 ± 2.09 | 1.040 | 0.301 |
ASA physical status, N (%) | 0.026 | 0.872 | ||
I | 0 (0%) | 0 (0%) | ||
II | 31 (68.9%) | 31 (70.5%) | ||
III | 14 (31.1%) | 13 (29.5%) | ||
IV | 0 (0%) | 0 (0%) | ||
Type of surgery, N (%) | 1.001 | 0.317 | ||
Total hip arthroplasty | 34 (75.6%) | 29 (65.9%) | ||
Hemiarthroplasty | 11 (24.4%) | 15 (34.1%) | ||
Intervertebral space, N (%) | 0.546 | 0.460 | ||
L23 | 25 (55.6%) | 21 (47.7%) | ||
L34 | 20 (44.4%) | 23 (52.3%) | ||
Surgery time (min), Median [IQR] | 70 [63 to 77] | 72.5 [63 to 82] | 982.5 | 0.950 |
Bleeding volume (ml), Mean ± SD | 300 ± 95 | 275 ± 155 | 909.0 | 0.504 |
Hospitalization days, Median [IQR] | 8 [7 to 8] | 7 [6.25 to 8] | 772.5 | 0.062 |